Tags: vaccine

10/17/2017

WSJ wisely reports on Ebola vaccines: ‘It is unknown…what antibody levels are needed to protect patients’

7/13/2017

It’s misleading to call results from phase 1 trials with 6 and 13 patients a ‘cancer breakthrough’